Michel P.
- Country
- France
- Department
- Service d'endocrinologie, gynécologie et diabétologie pédiatrique
Research Overview
- A Multicenter Randomized Non‑Inferiority Trial of Weekly Somatrogon versus Daily Somatropin in Pediatric Patients with Small‑for‑Gestational‑Age or Idiopathic Short Stature
- A Comparative Study of Somapacitan and Somatropin in Pediatric Patients with Short Stature Due to SGA, Turner Syndrome, Noonan Syndrome, or Idiopathic Short Stature
- Comparative Study of Somapacitan and Somatropin on Growth Outcomes in Pediatric Growth Hormone Deficiency
Data & Insights
Has run more than one trial at 19 of 61 partner sites.
Specializations
Growth Disorders
The investigator specializes in treating various pediatric growth conditions, with particular focus on growth hormone deficiency and children who were small for gestational age (SGA).
- Pediatric growth hormone therapy
- SGA with no catch-up growth
- Longitudinal growth assessment
Their research extends to innovative treatment approaches using weekly and daily growth hormone formulations.
Genetic Growth Conditions
The investigator studies growth disorders associated with genetic conditions, including Turner syndrome and Noonan syndrome.
- Turner syndrome management
- Noonan syndrome treatment
- Idiopathic short stature
Their work focuses on optimizing growth outcomes in children with genetic growth disorders.
Endocrine Disorders
The investigator conducts research in pediatric endocrine disorders, with expertise in Cushing's disease treatment in children and adolescents.
- Pediatric Cushing's disease
- Endocrine therapy in children
- Growth hormone disorders
Their research includes investigating new therapeutic options for pediatric endocrine conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.